24/04/24 BioTrinity A Discussion Around the Macro-Environmental Factors Impacting Life Sciences R&D Companies
24/04/24 BioTrinity Panel: An insight into the Inflation Reduction Act: Implications on Indication Selection, Clinical Development Strategy and M&A
23/04/24 BioTrinity Panel: Leading the Way – what it’s really like at the helm of one of the UK’s leading life sciences R&D SME’s
23/04/24 BioTrinity Panel: Regulatory Review – A Discussion on the Latest Regulatory Updates Impacting Biotech and Medtech SMEs; How to Ensure Compliance and Overcoming Challenges
23/04/24 BioTrinity Panel: An insider guide to Grant funding – what are your options and how to access it
